Tata India Pharma & Healthcare Fund-Regular Plan-Growth

Equity: Sectoral-Pharma and Healthcare Open Ended Scheme
Download Fund Card download share-white
arrow-up
NAV
₹ 31.9801 ₹ 0.24 (0.74 %)
as on 22-06-2026
Asset Size (AUM)
1,387.11 Cr
Launch Date
Dec 28, 2015
Invest in this scheme
Investment Objective
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Minimum Investment 5000.0
Minimum Top-up 1000.0
Investment Returns Since Launch in Dec 28, 2015
arrow-up

11.69

%
3 M
6 M
1 Y
3 Y
10 Y
Inception
Sharp Ratio
0.96 %
Expense Ratio
2.08%
Volatility
14.23 %
Fund House
Tata Mutual Fund
Fund Manager
Rajat Srivastava
Key Features
Scheme description
This fund has higher ups and downs compared to other equity funds but can give much higher returns. Investment in this fund can be made for a horizon of at least 5-7 years or more
Minimum Purchase Application Amount
Rs. 5000.0 (plus in multiples of Rs. 1000.0)
Entry Load
Not applicable
Exit Load
0.25% of NAV if redeemed /switched out before 30 days from the date of allotment.
Indicative Investment Horizon
5 Years and above
Asset Allocation
Fund's historical return comparison with other asset classes
Fund Performance
Fund's historical return comparison with other asset classes
Other Schemes of the Same Category
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Performance

Scheme Performance (%)

Data as on - 22-06-2026

Yearly Performance (%)

NAV Movement

Investment Returns Calculator
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
Peer Comparison
Scheme Name Inception Date 1 Year Return % 2 Year Return % 3 Year Return % 5 Year Return % 10 Year Return %
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 28-12-2015 8.51 10.55 21.67 13.79 13.45
Portfolio Analysis
Portfolio as on
Sector Allocation
Sector Allocation (%)
Portfolio Holdings
Company Allocation (%)
Sector Allocation
Portfolio Holdings